ZA201800485B - Pyrazolo[1,5-a]triazin-4-amine derivatives useful in therapy - Google Patents
Pyrazolo[1,5-a]triazin-4-amine derivatives useful in therapyInfo
- Publication number
- ZA201800485B ZA201800485B ZA2018/00485A ZA201800485A ZA201800485B ZA 201800485 B ZA201800485 B ZA 201800485B ZA 2018/00485 A ZA2018/00485 A ZA 2018/00485A ZA 201800485 A ZA201800485 A ZA 201800485A ZA 201800485 B ZA201800485 B ZA 201800485B
- Authority
- ZA
- South Africa
- Prior art keywords
- triazin
- pyrazolo
- therapy
- amine derivatives
- derivatives useful
- Prior art date
Links
- 238000002560 therapeutic procedure Methods 0.000 title 1
- QQOWHRYOXYEMTL-UHFFFAOYSA-N triazin-4-amine Chemical class N=C1C=CN=NN1 QQOWHRYOXYEMTL-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15173687 | 2015-06-24 | ||
| PCT/EP2016/063383 WO2016206999A1 (en) | 2015-06-24 | 2016-06-10 | Pyrazolo[1,5-a]triazin-4-amine derivatives useful in therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201800485B true ZA201800485B (en) | 2020-05-27 |
Family
ID=53483747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2018/00485A ZA201800485B (en) | 2015-06-24 | 2018-01-23 | Pyrazolo[1,5-a]triazin-4-amine derivatives useful in therapy |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10407429B2 (enExample) |
| EP (1) | EP3313842B1 (enExample) |
| JP (1) | JP6689299B2 (enExample) |
| CN (1) | CN107949563B (enExample) |
| AU (1) | AU2016284638B2 (enExample) |
| BR (1) | BR112017026061B1 (enExample) |
| CA (1) | CA2989722C (enExample) |
| RU (1) | RU2712196C2 (enExample) |
| WO (1) | WO2016206999A1 (enExample) |
| ZA (1) | ZA201800485B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017147526A1 (en) | 2016-02-26 | 2017-08-31 | The Board Of Trustees Of The Leland Stanford Junior University | Pi-kinase inhibitors with anti-infective activity |
| CN110520424B (zh) * | 2017-04-05 | 2022-06-21 | 库洛维公司 | 用于疗法的杂芳族化合物 |
| TWI795510B (zh) * | 2018-01-17 | 2023-03-11 | 英商葛蘭素史密斯克藍智慧財產發展有限公司 | PI4KIIIβ抑制劑 |
| CN118084937A (zh) | 2018-08-21 | 2024-05-28 | 杏林制药株式会社 | 双环杂芳族环衍生物 |
| WO2020074160A1 (en) | 2018-10-10 | 2020-04-16 | Curovir Ab | Condensed pyrimidine or pyridazine derivatives as antiviral agents |
| US12319696B2 (en) * | 2018-10-10 | 2025-06-03 | Curovir Ab | 2,6-dimethyl-n-((pyridin-4-yl)methyl)imidazo[1,2-b]pyridazin-8-amine and 2,5-dimethyl-n-[(pyridin-4-yl)methyl]pyrazolo[1,5-a]pyrimidin-7-amine derivatives for treating viral infections |
| WO2020146657A1 (en) * | 2019-01-11 | 2020-07-16 | The Board Of Trustees Of The Leland Stanford Junior University | Pi4-kinase inhibitors with anti-cancer activity |
| CN114174275A (zh) | 2019-03-21 | 2022-03-11 | 小利兰·斯坦福大学托管委员会 | Pi4-激酶抑制剂及其使用方法 |
| WO2021032611A1 (en) | 2019-08-20 | 2021-02-25 | Curovir Ab | Heteroaromatic compounds useful in therapy |
| CN113801119B (zh) * | 2021-08-30 | 2022-09-30 | 新乡医学院 | 一种吡唑并[1,3,5]三嗪类化合物的合成方法 |
| WO2024184442A1 (en) | 2023-03-09 | 2024-09-12 | Curovir Ab | Compound and formulation for systemic therapy by oral transmucosal administration |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6313124B1 (en) * | 1997-07-23 | 2001-11-06 | Dupont Pharmaceuticals Company | Tetrazine bicyclic compounds |
| US6191131B1 (en) * | 1997-07-23 | 2001-02-20 | Dupont Pharmaceuticals Company | Azolo triazines and pyrimidines |
| ATE301657T1 (de) * | 1998-01-28 | 2005-08-15 | Bristol Myers Squibb Pharma Co | Azolo-pyrimidine |
| US6372743B1 (en) * | 1999-09-30 | 2002-04-16 | Neurogen Corporation | Certain alkylene diamine-substituted pyrazlo (1,5-a)-1,5-pyrimidines and pyrazolo (1,5-a) 1,3,5-triazines |
| GB0716292D0 (en) * | 2007-08-21 | 2007-09-26 | Biofocus Dpi Ltd | Imidazopyrazine compounds |
| FR2943058B1 (fr) | 2009-03-11 | 2011-06-03 | Centre Nat Rech Scient | Derives de pyrazolo°1,5-a!-1,3,5-triazines, leur preparation et leur application en therapeutique. |
| US8633198B1 (en) * | 2011-09-20 | 2014-01-21 | Nant Holdings Ip, Llc | Small molecule inhibitors of influenza A RNA-dependent RNA polymerase |
| EP2634190A1 (en) * | 2012-03-01 | 2013-09-04 | Lead Discovery Center GmbH | Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhinitors |
| EP2634189A1 (en) | 2012-03-01 | 2013-09-04 | Lead Discovery Center GmbH | Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhibitors |
| US9573954B2 (en) * | 2012-11-16 | 2017-02-21 | University Health Network | Pyrazolopyrimidine compounds |
-
2016
- 2016-06-10 CA CA2989722A patent/CA2989722C/en active Active
- 2016-06-10 JP JP2017566742A patent/JP6689299B2/ja active Active
- 2016-06-10 RU RU2018102449A patent/RU2712196C2/ru active
- 2016-06-10 EP EP16731540.7A patent/EP3313842B1/en active Active
- 2016-06-10 BR BR112017026061-1A patent/BR112017026061B1/pt active IP Right Grant
- 2016-06-10 WO PCT/EP2016/063383 patent/WO2016206999A1/en not_active Ceased
- 2016-06-10 AU AU2016284638A patent/AU2016284638B2/en active Active
- 2016-06-10 US US15/737,907 patent/US10407429B2/en active Active
- 2016-06-10 CN CN201680036895.1A patent/CN107949563B/zh active Active
-
2018
- 2018-01-23 ZA ZA2018/00485A patent/ZA201800485B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2018102449A3 (enExample) | 2019-08-20 |
| EP3313842B1 (en) | 2020-04-15 |
| HK1254809A1 (en) | 2019-07-26 |
| BR112017026061A2 (pt) | 2018-08-14 |
| EP3313842A1 (en) | 2018-05-02 |
| BR112017026061B1 (pt) | 2023-03-28 |
| JP2018522861A (ja) | 2018-08-16 |
| WO2016206999A1 (en) | 2016-12-29 |
| AU2016284638A1 (en) | 2018-01-18 |
| NZ738280A (en) | 2024-10-25 |
| AU2016284638B2 (en) | 2020-01-23 |
| CN107949563B (zh) | 2020-06-05 |
| US20180298007A1 (en) | 2018-10-18 |
| RU2712196C2 (ru) | 2020-01-24 |
| US10407429B2 (en) | 2019-09-10 |
| RU2018102449A (ru) | 2019-07-24 |
| CA2989722C (en) | 2023-09-19 |
| CA2989722A1 (en) | 2016-12-29 |
| JP6689299B2 (ja) | 2020-04-28 |
| CN107949563A (zh) | 2018-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL260923B (en) | History of pyrazolo[5,1-a]pyrazin-4-yl as jak inhibitors | |
| ZA201800485B (en) | Pyrazolo[1,5-a]triazin-4-amine derivatives useful in therapy | |
| IL266305B (en) | History of [4,2,1]triazolo[5,1-a]pyrimidine as pde2 inhibitors | |
| ZA201902562B (en) | Pyrazolo [1,5-a]pyridine derivatives and their use as pesticides | |
| ZA201802842B (en) | [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compound | |
| IL254224A0 (en) | 7-substituted 5-alkyl-[4,2,1]triazolo[5,1-a]pyrimidine derivatives as pde2 inhibitors | |
| EP3107914B8 (en) | Pyrazolo[1,5-a]pyrimidine-5,7-diamine compounds as cdk inhibitors and their therapeutic use | |
| IL290419A (en) | Imidazo[a-1,5]pyrazine derivatives as inhibitors of pi3k delta | |
| IL272988A (en) | Imidazo-[1,5-A]pyrazine derivatives as PI3K-delta inhibitors | |
| IL250104B (en) | [1,2,4]triazolo[3-b,4]pyridines for the treatment of proliferative diseases | |
| GB201516220D0 (en) | Pyrrolo[2,3-d]pyrimidin-4-amine compounds and their use in treating cancer | |
| IL253427A0 (en) | The result of pyrazolo[3,4-d]pyrimidine and its use in the treatment of Jericho rose | |
| GB201613403D0 (en) | Pyrrolo[2,3-d]pyrimidin-4-amine compounds and their use in treating cancer |